Ozgun, A. Et Al. 2025. Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study. MOLECULAR AND CLINICAL ONCOLOGY , vol.22, no.6 .

Ozgun, A., Mustafayev, F. N. A., Dogan, I., Vatansever, S., Eryilmaz, M. K., ERDOĞAN, A. P., ... Ozturk, G. G.(2025). Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study. MOLECULAR AND CLINICAL ONCOLOGY , vol.22, no.6.

Ozgun, Alpaslan Et Al. "Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study," MOLECULAR AND CLINICAL ONCOLOGY , vol.22, no.6, 2025

Ozgun, Alpaslan Et Al. "Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study." MOLECULAR AND CLINICAL ONCOLOGY , vol.22, no.6, 2025

Ozgun, A. Et Al. (2025) . "Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study." MOLECULAR AND CLINICAL ONCOLOGY , vol.22, no.6.

@article{article, author={Alpaslan Ozgun Et Al. }, title={Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study}, journal={MOLECULAR AND CLINICAL ONCOLOGY}, year=2025}